Lanean...
Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectivene...
Gorde:
| Argitaratua izan da: | Pharmaceuticals (Basel) |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8001969/ https://ncbi.nlm.nih.gov/pubmed/33807743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030217 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|